HIV-associated multicentric Castleman’s disease after initiation of antiretroviral therapy: experience of a European centre
Authors:
- 4 March 2014
- journal article
- Published by Springer Nature in Infection
- Vol. 42 (4) , 791-793
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Immune reconstitution inflammatory syndrome associated with Kaposi sarcomaAIDS, 2013
- Improved outcome with rituximab in patients with HIV-associated multicentric Castleman diseaseBlood, 2011
- Pathogenesis and prevention of immune reconstitution disease during antiretroviral therapyExpert Review of Anti-infective Therapy, 2011
- How I treat HIV-associated multicentric Castleman diseaseBlood, 2010
- Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitionsThe Lancet Infectious Diseases, 2010
- Highly active antiretroviral therapy alone may be an effective treatment for HIV-associated multi-centric Castleman's diseaseHaematologica, 2010
- The role of immune suppression and HHV-8 in the increasing incidence of HIV-associated multicentric Castleman’s diseaseAnnals of Oncology, 2009
- An Unusual Cluster of Cases of Castleman's Disease during Highly Active Antiretroviral Therapy for AIDSNew England Journal of Medicine, 1999